Premium
Designer biocatalysts for direct incorporation of exogenous galactose into globotriose
Author(s) -
Long Lingfeng,
Azadi Parastoo,
Chen Rachel
Publication year - 2020
Publication title -
biotechnology and bioengineering
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.136
H-Index - 189
eISSN - 1097-0290
pISSN - 0006-3592
DOI - 10.1002/bit.27198
Subject(s) - galactose , lactose , galactosyltransferase , chemistry , biochemistry , uridine diphosphate , nucleotide salvage , escherichia coli , uridine diphosphate glucose , enzyme , gene , nucleotide
Galactose is ubiquitous. The synthesis of galactose‐containing oligosaccharides using Leloir galactosyltransferase requires uridine diphosphate (UDP)‐galactose as the precursor. Of all UDP‐galactose synthesis pathways developed for in vitro synthesis, the salvage pathway represents the simplest route. In this study, for the first time, we designed and constructed an Escherichia coli strain to use salvage pathway for UDP‐galactose synthesis, demonstrating effective and direct incorporation of exogenous galactose into globotriose (Gb3). Successful establishment of salvage pathway enabled a complete delineation of carbon and energy source. Consequently, the designed biocatalyst was able to achieve high yield synthesis from galactose (0.95 moles of Gb3/moles galactose consumed) and a high product titer (2 g/L) in shaker flask within 24 hr. Elimination of limitation in acceptor sugar via homologous overexpression of LacY, the transporter for lactose, further improved the synthesis, raising Gb3 titer to 6 g/L in 24 hr and 7.5 g/L in 48 hr. The design principles successfully demonstrated in this study could be broadly applied for synthesis of other galactose‐containing oligosaccharides. This study also illustrates a valid strategy to overcome limitation in the transport of acceptor sugar. As lactose is one of the most important basal structures, the significant improvement in synthesis through its enhanced transport could be emulated in numerous other lactose‐based oligosaccharides.